GlassScriptPhysician profile
Hashim Khan
NPI 1154504900
$14,801.14
in general payments reported to CMS, 2019-2025
43 companies · $7,650 in 2025
The $7,650 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,793 · 2020: $1,041 · 2021: $692 · 2022: $734 · 2023: $861 · 2024: $2,031 · 2025: $7,650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,132 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,000 · Consulting Fee: $1,500 · Travel and Lodging: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,131.71 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,000.00 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $910.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,599.70 | 2019-2025 | Esprit, Diamondback Peripheral, Dragonfly Opstar |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,558.24 | 2019-2025 | Lifevest |
| Shockwave Medical, INC | $1,496.53 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $830.70 | 2021-2025 | Abre, Wholey, In.Pact Admiral |
| Stryker Corporation | $819.78 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Limflow System |
| Philips North America LLC | $700.00 | 2019 | |
| Endologix LLC | $619.72 | 2025 | Torus Stent Graft System, Endocross Device |
| Cardiovascular Systems INC. | $477.33 | 2020-2022 | |
| Terumo Medical Corporation | $419.04 | 2023-2024 | Metacross Otw, Navicross, Azur Cx Detachable |
| Abiomed | $406.53 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $216.83 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $182.49 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $127.43 | 2019 | |
| Novo Nordisk INC | $126.52 | 2022-2025 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $123.98 | 2021-2025 |
Show all 42 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hashim Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.